
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- OTC medicines (31) Apply OTC medicines filter
- Prescription medicines (25) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Draft Guidance on the use of the term 'Quantified by Input' for Listed complementary medicines
Closed on 4 November 2009
Draft Code of Good Wholesaling Practice for Medicines in Schedules 2, 3, 4 and 8
Closed on 23 October 2009
Review of Schedule 1 to TGO 80 Child-resistant packaging requirements for medicines
Closed on 23 September 2009
Required Advisory Statements for Medicine Labels - proposed update 5
Closed on 20 August 2009
TGA communications and consultation processes: Online survey 2009
Closed on 21 June 2009
Draft cost recovery impact statements (annual review of fees and charges 2009-10)
Closed on 8 April 2009
Draft Guideline for levels and kinds of evidence for listed medicines with indications and claims for weight loss
Closed on 3 April 2009
Draft guidance on the regulation of custom made medical devices
Closed on 31 March 2009
Use of third party conformity assessment bodies for medical devices supplied in Australia
Closed on 27 March 2009
Intention to amend the definition of ‘British Pharmacopoeia’ under the Therapeutic Goods Act 1989
Closed on 13 February 2009